Effectiveness and tolerability of dietary supplementation with a combination of omega-3 polyunsaturated fatty acids and antioxidants in the treatment of dry eye symptoms: Results of a prospective study

Clinical Ophthalmology

Volumn 8, Issue , 2014, Pages 169-176

  Oleñik, Andrea ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Antioxidants; Brudysec 1.5 g; Dry eye symptoms; Nutraceutics; Omega 3; Polyunsaturated fatty acids

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARTIFICIAL TEAR; ASCORBIC ACID; BRUDYSEC; COPPER; CYSTEINE; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; GLUTATHIONE; ICOSAPENTAENOIC ACID; MAGNESIUM; NUTRACEUTICAL; OMEGA 3 FATTY ACID; RETINOL; SELENIUM; TYROSINE; UNCLASSIFIED DRUG; ZINC;

ADULT; ARTICLE; BLURRED VISION; CONTACT LENS; DIARRHEA; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; DRY EYE; EYE DISCOMFORT; EYE PAIN; EYE REDNESS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAUSEA; OCULAR PRURITUS; OPEN STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; TASTE DISORDER; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING;

EID: 84891846199     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S54658     Document Type: Article

References (23)

1. Perry HD. Dry eye disease: pathophysiology, classification, and diagnosis. Am J Manag Care. 2008;14(Suppl 3):S79-S87.
2. Dartt DA. Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases. Prog Retin Eye Res. 2009;28(3): 155-177.
3. Behrens A, Doyle JJ, Stern L, et al; Dysfunctional tear syndrome study group. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25:900-907.
4. No authors listed. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):93-107.
5. No authors listed. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):75-92.
6. Butovich IA. Cholesteryl esters as a depot for very long chain fatty acids in human meibum. J Lipid Res. 2009;50(3):501-513.
7. Holly FJ, Lemp MA. Tear physiology and dry eyes. Surv Ophthalmol. 1977;22(2):69-87.
8. Rand AL, Asbell PA. Nutritional supplements for dry eye syndrome. Curr Opin Ophthalmol. 2011;22(4):279-282.
9. de Lorgeril M, Salen P. New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids. BMC Med. 2012;10:50.
10. Swanson D, Block R, Mousa SA. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr. 2012;3(1):1-7.
11. Nichols PD, Petrie J, Singh S. Long-chain omega-3 oils-an update on sustainable sources. Nutrients. 2010;2(6):572-585.
12. Jenkins DJ, Josse AR. Fish oil and omega-3 fatty acids. CMAJ. 2008;178(2):150.
13. McCabe E, Narayanan S. Advancements in anti-inflammatory therapy for dry eye syndrome. Optometry. 2009;80(10):555-566.
14. Kangari H, Eftekhari MH, Sardani S, et al. Short-term consumption of oral omega-3 and dry eye syndrome. Ophthalmology. 2013;120(11): 2191-2196.
15. Pinazo-Durán MD, Galbis-Estrada C, Pons-Vázquez S, Cantú-Dibildox J, Marco-Ramírez C, Benítez-del-Castillo J. Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders. Clin Interven Aging. 2013;8:139-148.
16. Rosenberg ES, Asbell PA. Essential fatty acids in the treatment of dry eye. Ocul Surf. 2010;8(1):18-28.
17. Galbis-Estrada C, Pinazo-Durán MD, Cantú-Dibildox J, Marco-Ramírez C, Díaz-Llopis M, Benítez-del-Castillo J. Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids. Clin Interv Aging. 2013;8: 711-719.
18. He J, Bazan HE. Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery. Prostaglandins Leukot Essent Fatty Acids. 2010;82(4-6):319-325.
19. Wojtowicz JC, Butovich I, Uchiyama E, Aronowicz J, Agee S, McCulley JP. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea. 2011;30(3):308-314.
20. Roncone M, Bartlett H, Eperjesi F. Essential fatty acids for dry eye: a review. Cont Lens Anterior Eye. 2010;33(2):49-54; quiz 100.
21. Surette ME. The science behind dietary omega-3 fatti acids. CMAJ. 2008;178(2):177-180.
22. Olenik A, Jiménez-Alfaro I, Alejandre-Alba N, Mahillo-Fernández I. A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction. Clin Interv Aging. 2013;8:1133-1138.
23. Regulation (EU) No. 432/2012 of the European Parliament and of the Council of 16 May 2012. Available from http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2012:136:0001:0040:en:PDF. Accessed December 10, 2013.